Short-circuiting Phase 3 trials may actually happen in someplace like Brazil with a rising infection rate. If the trial shows that the vaccine arm never gets infected and the control arm does at the same rate as the rest of the population, the statistics can tell them to end the trial because it's passed the test.

Of course, that does not tell you how long the immunity lasts, but they are hoping for years and nobody wants to wait that long.